Helen Hill

Senior Clinical Research Associate at Liverpool School of Tropical Medicine

Risk Adapted Approach – Neonatal Pharmacokinetic Clinical Trial of Ciprofloxacin in Critical Care. Part 2

Helen Hill, 28 March 2019 - Compliance matters, Good clinical practice

The benefits of risk assessment in clinical trial planning and how a more proportionate regulatory approach can overcome potential barriers to completing trials

Risk-adapted Approach: Neonatal Pharmacokinetic Clinical Trial of Ciprofloxacin in Critical Care - Part 1

Helen Hill, 31 January 2019 - Compliance matters, Good clinical practice

Applying risk-adapted approaches – how this worked for a researcher in neonatal trials.

About the MHRA Inspectorate Blog

This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.

Find out more

Categories

Follow us on social media

• MHRA Twitter
• MHRA Medicines Twitter
• LinkedIn company page

Sign up and manage updates

• Email
• Atom

Printing Posts

You can print blog posts using the keyboard shortcuts "Control P" or "Command P".

Other MHRA Blogs

MedRegs

Comments and moderation

Read our guidelines

Recent posts

• MHRA Good Clinical and Laboratory Practice Symposia (11 and 12 February 2025)
• Public Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2
• DSUR Submissions and Fees are Changing from 1 June 2024
• Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium
• Pilot GMP Single Inspection Program